15h
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Every quarter in 2024 was better than the last. M&A ended the year on a strong, positive note, with the industrials and TMT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results